Forward Science has received clearance from the Food and Drug Administration (FDA) for its Orapeutic non-opioid oral pain relief gel, which is designed for oral wounds, mouth sores, injuries, and ulcers of the oral mucosa. It adheres to the oral tissue and forms a protective barrier around the wound to further prevent irritation and contamination. Plus, it also maintains a moist would environment, the company reports.
Dentists and oral surgeons prescribe the most opioids to patients between the ages of 10 and 19, Forward Science says, which is when the still developing brain is particularly susceptible to addiction. Considering recent concerns about opioid prescriptions and addiction in dentistry, the company says it has been working on a non-drug option to manage oral pain. Forward Science expects to launch Orapeutic early in 2020.
Related Articles
Partnership Aims to Improve Oral Cancer Detection
Pitt School of Dental Medicine Establishes Opioid-Free Treatment Guidelines
Guidelines Improve Photobiomodulation Therapy for Oral Mucositis
